STOCK TITAN

Prestige Consmr Healthcare Inc - PBH STOCK NEWS

Welcome to our dedicated page for Prestige Consmr Healthcare news (Ticker: PBH), a resource for investors and traders seeking the latest updates and insights on Prestige Consmr Healthcare stock.

Overview

Prestige Consumer Healthcare Inc is an established name in the over-the-counter healthcare industry, renowned for its commitment to product innovation, quality, and trusted brands. With a diversified portfolio that includes products in eye care, oral care, women’s health, pain relief, and more, the company efficiently addresses everyday consumer needs. As a company that has built enduring brand trust across generations, it operates with a dual focus on maintaining traditional values and embracing innovation to adapt to changing lifestyles and consumer expectations.

Core Product Portfolio and Business Model

The company’s extensive product portfolio is designed to serve a broad spectrum of healthcare necessities. From eye care solutions like Clear Eyes to specialized oral care products and feminine hygiene solutions such as Summer’s Eve, Prestige Consumer Healthcare delivers products that cater to various aspects of personal wellness. By focusing on meticulous product stewardship and innovation, the company reinforces its market position as the largest independent provider of OTC healthcare products in North America. Its business model centers around direct product sales, which are executed through an integrated supply chain that leverages both domestic and international distribution channels.

Market Position and Competitive Landscape

Operating within the highly competitive consumer healthcare market, Prestige Consumer Healthcare stands out through its commitment to quality, tailored product development, and responsiveness to consumer needs. The company’s ability to swiftly adapt to supply-demand imbalances, while managing a vast portfolio of trusted brands, distinguishes its operational narrative from its competitors. This nimbleness, combined with a focus on detailed attention to every product, reinforces its competitive edge in both North American and selected international markets.

Innovation, Quality, and Consumer Trust

At the heart of the company’s philosophy is a deep commitment to product innovation and quality assurance. Driven by a culture that blends traditional brand values with modern innovation, Prestige Consumer Healthcare continually updates its product offerings to meet evolving consumer preferences and dynamic lifestyle trends. This approach not only nurtures a loyal customer base but also provides a framework for continuous quality improvement and operational excellence.

Global Reach and Operational Excellence

Despite its strong presence in North America, the company extends its reach to international markets including Canada, Australia, and other key regions. Its ability to scale production and distribution while addressing market-specific nuances highlights an operational strategy that leverages global best practices. The company’s structured yet flexible operational model allows it to optimize production and supply chain management, ensuring that consumer healthcare needs are met reliably, even under challenging market conditions.

Financial and Strategic Insights

While detailed financial metrics are not the focus here, the company’s sustained ability to generate robust free cash flow, manage debt prudently, and repurchase shares demonstrates disciplined capital allocation. This financial prudence underscores a broader strategic approach that emphasizes long-term value creation. By aligning operational efficiency with strategic marketing and product development, Prestige Consumer Healthcare efficiently navigates market fluctuations and competitive pressures.

Commitment to Stakeholders

Transparency and clear communication with investors and consumers have been critical to the company’s sustained success. Its consistent performance in delivering quality products, coupled with a flexible business model, reflects a balanced approach that prioritizes both operational efficiency and customer satisfaction. This commitment to stakeholder trust is a cornerstone of its legacy and continues to drive its market relevance.

Conclusion

In summary, Prestige Consumer Healthcare Inc exemplifies a company that combines heritage with innovation. Its deep-rooted commitment to delivering trusted OTC healthcare products, underpinned by strategic operational excellence and a keen focus on consumer needs, places it in a significant position within the market. Whether through maintaining quality in traditional product segments or adapting to new consumer demands, the company continues to redefine excellence in the consumer healthcare industry.

Rhea-AI Summary
Prestige Consumer Healthcare Inc. (PBH) is set to release its fiscal 2024 fourth quarter and year-end earnings results on May 14, 2024. A conference call to discuss the results will be held on May 15th, at 8:30 a.m. ET. Investors can access the webcast and replay on the Investor Relations page of the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.01%
Tags
-
Rhea-AI Summary
Dramamine®, a Prestige Consumer Healthcare brand, commemorates the joint anniversary of the barf bag and Dramamine® by launching 'The Last Barf Bag' campaign. The campaign aims to revive the cultural significance of barf bags through a documentary, upcycled bag collection, and a wearable art piece. Dramamine® celebrates its success in motion sickness relief while acknowledging the fading use of barf bags.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.76%
Tags
none
-
Rhea-AI Summary
Prestige Consumer Healthcare Inc. (NYSE:PBH) reported a revenue of $282.7 million in Q3, up 2.6% versus the prior year, with a diluted EPS of $1.06, up 2.2% versus the prior year. The company raised its full-year fiscal 2024 earnings outlook to approximately $4.33, and reduced its leverage ratio to 2.9x at quarter end. The revenue growth was driven by strong performance in the Eye & Ear Care category in North America and the Hydralyte® brand in the International segment. The company's net cash provided by operating activities and non-GAAP free cash flow increased significantly in Q3 and the first nine months of fiscal 2024. The North American OTC Healthcare segment revenues were flat, while the International OTC Healthcare segment revenues increased by approximately 10% in Q3 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.36%
Tags
Rhea-AI Summary
Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company, has announced a voluntary recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid due to elevated levels of benzene found in two lots of the product. Benzene is classified as a human carcinogen, and exposure to it can result in life-threatening conditions. The recall affects specific lot codes of the product, and consumers are advised to stop using the product immediately and contact the company for a full refund. No serious adverse events have been reported to date.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
none
-
Rhea-AI Summary
Prestige Consumer Healthcare Inc. (PBH) will release its fiscal 2024 third quarter earnings on February 8, 2024. The company will host a conference call to discuss the results at 8:30 a.m. ET. The live webcast and phone participation details are available on the Investor Relations page of www.prestigeconsumerhealthcare.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.51%
Tags
-
Rhea-AI Summary
Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (ticker symbol not provided), is voluntarily recalling one lot of Americaine® 20% Benzocaine Topical Anesthetic Spray due to low levels of benzene in the propellant, posing a potential risk of cancer. No serious adverse events have been reported related to this recall.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.41%
Tags
none
Rhea-AI Summary
Insight Pharmaceuticals (Prestige Consumer Healthcare Inc.) is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder due to elevated levels of benzene in the propellant. Benzene is a human carcinogen. The affected lots were distributed nationwide in the United States through a limited number of retailers and online. Consumers can contact the company for a full refund and should stop using the product immediately if they have the affected lot codes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
none
-
Rhea-AI Summary
Prestige Consumer Healthcare Inc. reported revenue of $286.3 million in Q2, a decrease of 0.7% compared to the prior year. Diluted EPS was $1.07, up 5.4% from the prior year. The company reduced its leverage ratio to 3.0x. The full-year outlook for fiscal 2024 remains unchanged.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
-
Rhea-AI Summary
Prestige Consumer Healthcare Inc. to release fiscal 2024 Q2 earnings on November 2, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
Rhea-AI Summary
Prestige Consumer Healthcare to present at Barclays Global Consumer Staples Conference on September 7, 2023 at 3:00 p.m. ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
conferences

FAQ

What is the current stock price of Prestige Consmr Healthcare (PBH)?

The current stock price of Prestige Consmr Healthcare (PBH) is $82.85 as of April 4, 2025.

What is the market cap of Prestige Consmr Healthcare (PBH)?

The market cap of Prestige Consmr Healthcare (PBH) is approximately 3.7B.

What core segments does Prestige Consumer Healthcare Inc operate in?

The company specializes in over-the-counter healthcare products, spanning segments such as eye care, oral care, women's health, pain relief, and other personal wellness products.

How does the company maintain its reputation for quality and innovation?

Prestige Consumer Healthcare Inc focuses on rigorous product stewardship and continuous innovation, ensuring that each product meets high quality standards and is tailored to evolving consumer needs.

What regions does Prestige Consumer Healthcare serve?

The company has a strong presence in North America and extends its reach to international markets including Canada, Australia, and selected other regions.

How does the company differentiate itself from competitors?

Its ability to be both a large-scale provider and a nimble operator allows for detailed product attention and rapid adaptation to supply-demand dynamics, thus setting it apart in a competitive marketplace.

What is the primary business model of Prestige Consumer Healthcare Inc?

The business model is centered on direct product sales through a well-integrated supply chain that supports both domestic and international distribution, emphasizing product quality and consumer trust.

What role does product innovation play in the company’s strategy?

Innovation is at the core of the company’s operations, driving updates to the product portfolio to meet changing lifestyle demands and ensuring that consumer needs are consistently met.

How does the company manage its supply chain challenges?

By maintaining a flexible operational model, the company effectively navigates supply chain constraints to ensure that popular products reach the market in a timely manner, thereby sustaining consumer confidence.

What approach does the company take towards financial management?

The company emphasizes prudent financial management through strategies such as disciplined capital allocation, maintaining robust free cash flow, and managing debt efficiently to support long-term value creation.
Prestige Consmr Healthcare Inc

NYSE:PBH

PBH Rankings

PBH Stock Data

3.68B
48.86M
1.3%
109.04%
3.07%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
TARRYTOWN